Dr George Follows discusses the role of CLL patients, oral therapies and new medicines.

The new targeted therapies will require discipline and engagement by patients to ensure they take their medications to stay in remission. Longer term the research community is working towards novel none chemo combinations that may produce a durable MRD status, removing the need then for continued medication, this could one day translate into a cure.